Mount Sinai announced this week that its Tisch Cancer Center is now among the top U.S. research institutions to automate transfer of clinical data from its electronic health record system into clinical trial platforms.
WHY IT MATTERS
By integrating the Archer platform from IgniteData with Epic, Mount Sinai is able to connect physicians and medical researchers, helping them share information more accurately and efficiently during oncology trials.
Before, research teams had to re-enter the same information into multiple systems, including electronic data capture systems – which are used by clinical trial sponsors to store study information for analysis and regulatory submission. Such a repetitive process can lead to transcription errors, administrative burden and delays.
But the new capability streamlines how clinical information is exchanged between patient visits and research databases in real time. With Archer, say Mount Sinai researchers, structured data flows securely and automatically from Epic into sponsor EDC systems with help from HL7's FHIR standard.
Mount Sinai leaders note that pilots of the technology have shown reductions of up to 70% in manual transcription time – improving both data quality and workforce efficiency.
That can also allow clinical trial oversight bodies to review aggregated safety and research data more quickly, according to Mount Sinai, helping "identify trends, respond to potential concerns, and accelerate decision-making during development of new therapies."
The new technology is now live across Mount Sinai, starting with oncology, health system leaders say, noting that more specialties will follow.
THE LARGER TREND
New York-based Mount Sinai has been busy recently, developing a promising new tool that could help detect biases in AI datasets, developing a genAI-based medical education platform and launching a new center aimed at AI-enabled pediatrics.
Earlier this year, Lisa Stump, the health system's newly appointed chief digital information officer, offered an up-close look at its digital transformation goals, which included bridging clinical and research missions and managing mountains of ever-growing data.
ON THE RECORD
"This integration marks a turning point in how we conduct clinical trials," said Dr. Karyn Goodman, vice chair of clinical research in the Department of Radiation Oncology and associate director of clinical research at Tisch Cancer Institute. "By automating data transfer and improving accuracy at the source, we can conduct more studies, reach more patients, and deliver promising therapies faster."
"Our research workforce is highly specialized, and their time is best spent with patients – not retyping data," added Therica Miller, executive director of enterprise cancer clinical research at Tisch. "This effort improves accuracy, reduces burnout, and enhances our capacity to deliver more trials to more communities."
Mike Miliard is executive editor of Healthcare IT News
Email the writer: mmiliard@himss.org
Healthcare IT News is a HIMSS publication.
